In Reply We appreciate Mr Boutin’s perspective on our recent article.1 In our study, we found inconsistent disclosure practices regarding both industry-derived financial support and industry affiliations of board members among patient advocacy organizations (PAOs) in dermatology, leading to a lack of transparency around potential conflicts of interest.